BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20081364)

  • 1. Yin Yang 1 overexpression in diffuse large B-cell lymphoma is associated with B-cell transformation and tumor progression.
    Castellano G; Torrisi E; Ligresti G; Nicoletti F; Malaponte G; Traval S; McCubrey JA; Canevari S; Libra M
    Cell Cycle; 2010 Feb; 9(3):557-63. PubMed ID: 20081364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
    Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1.
    Ramkumar C; Cui H; Kong Y; Jones SN; Gerstein RM; Zhang H
    Nat Commun; 2013; 4():2598. PubMed ID: 24121673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of YY1 in Differentiated Thyroid Cancer.
    Arribas J; Castellví J; Marcos R; Zafón C; Velázquez A
    Endocr Pathol; 2015 May; 26(2):111-8. PubMed ID: 25698133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oncogenic role of Yin Yang 1.
    Zhang Q; Stovall DB; Inoue K; Sui G
    Crit Rev Oncog; 2011; 16(3-4):163-97. PubMed ID: 22248053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma.
    Xue T; Lin JX; He YQ; Li JW; Liu ZB; Jia YJ; Zhou XY; Li XQ; Yu BH
    Heliyon; 2024 Jan; 10(2):e24376. PubMed ID: 38312674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yin yang 1 expression in human tumors.
    Zaravinos A; Spandidos DA
    Cell Cycle; 2010 Feb; 9(3):512-22. PubMed ID: 20081375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Yin and Yang of YY1 in tumor growth and suppression.
    Khachigian LM
    Int J Cancer; 2018 Aug; 143(3):460-465. PubMed ID: 29322514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yin Yang 1 regulates ITGAV and ITGB1, contributing to improved prognosis of colorectal cancer.
    Sato N; Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohira G; Matsubara H; Ohtsuka M
    Oncol Rep; 2022 May; 47(5):. PubMed ID: 35266011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yin-Yang-1 decreases Fas-induced apoptosis in acute lymphoblastic leukemia under hypoxic conditions: its implications in immune evasion.
    Martínez-Torres E; López-Pérez TV; Morales-Martínez M; Huerta-Yepez S
    Bol Med Hosp Infant Mex; 2020; 77(4):186-194. PubMed ID: 32713953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27.
    Wan M; Huang W; Kute TE; Miller LD; Zhang Q; Hatcher H; Wang J; Stovall DB; Russell GB; Cao PD; Deng Z; Wang W; Zhang Q; Lei M; Torti SV; Akman SA; Sui G
    Am J Pathol; 2012 May; 180(5):2120-33. PubMed ID: 22440256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The involvement of the transcription factor Yin Yang 1 in cancer development and progression.
    Castellano G; Torrisi E; Ligresti G; Malaponte G; Militello L; Russo AE; McCubrey JA; Canevari S; Libra M
    Cell Cycle; 2009 May; 8(9):1367-72. PubMed ID: 19342874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.
    Kaufhold S; Garbán H; Bonavida B
    J Exp Clin Cancer Res; 2016 May; 35():84. PubMed ID: 27225481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.
    Huerta-Yepez S; Liu H; Baritaki S; Del Lourdes Cebrera-Muñoz M; Rivera-Pazos C; Maldonado-Valenzuela A; Valencia-Hipolito A; Vega MI; Chen H; Berenson JR; Bonavida B
    Int J Oncol; 2014 Sep; 45(3):1184-92. PubMed ID: 24970600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galiximab signals B-NHL cells and inhibits the activities of NF-κB-induced YY1- and snail-resistant factors: mechanism of sensitization to apoptosis by chemoimmunotherapeutic drugs.
    Martinez-Paniagua MA; Vega MI; Huerta-Yepez S; Baritaki S; Vega GG; Hariharan K; Bonavida B
    Mol Cancer Ther; 2012 Mar; 11(3):572-81. PubMed ID: 22267549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: A computational study.
    Hafsi S; Candido S; Maestro R; Falzone L; Soua Z; Bonavida B; Spandidos DA; Libra M
    Oncol Lett; 2016 Feb; 11(2):1021-1025. PubMed ID: 26893685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma.
    Thompson MA; Edmonds MD; Liang S; McClintock-Treep S; Wang X; Li S; Eischen CM
    Hum Pathol; 2016 Apr; 50():118-26. PubMed ID: 26997445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Krüppel-Like Factor 4 (KLF4) expression through the transcription factor Yin-Yang 1 (YY1) in non-Hodgkin B-cell lymphoma.
    Morales-Martinez M; Valencia-Hipolito A; Vega GG; Neri N; Nambo MJ; Alvarado I; Cuadra I; Duran-Padilla MA; Martinez-Maza O; Huerta-Yepez S; Vega MI
    Oncotarget; 2019 Mar; 10(22):2173-2188. PubMed ID: 31040909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of Yin Yang 1 enhances anticancer effects of cisplatin through protein phosphatase 2A-mediated T308 dephosphorylation of AKT.
    Zhao L; Li R; Gan YH
    Cell Death Dis; 2018 Jul; 9(7):747. PubMed ID: 29970878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A strong host response and lack of MYC expression are characteristic for diffuse large B cell lymphoma transformed from nodular lymphocyte predominant Hodgkin lymphoma.
    Schuhmacher B; Rengstl B; Döring C; Bein J; Newrzela S; Brunnberg U; Kvasnicka HM; Vornanen M; Küppers R; Hansmann ML; Hartmann S
    Oncotarget; 2016 Nov; 7(44):72197-72210. PubMed ID: 27708232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.